We are live on ! Find out more
Temasek Holdings

Temasek Holdings Portfolio holdings

AUM $30.5B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+13.98%
3 Year Est. Return
+73.05%
5 Year Est. Return
+59.18%
10 Year Est. Return
+409.11%
AUM
$17.2B
AUM Growth
+$1.66B
Cap. Flow
+$584M
Cap. Flow %
3.4%
Top 10 Hldgs %
78.01%
Holding
63
New
4
Increased
16
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$180M
2
VIRT icon
Virtu Financial
VIRT
+$135M
3
TCOM icon
Trip.com Group
TCOM
+$106M
4
MA icon
Mastercard
MA
+$86.8M
5
CHRS icon
Coherus Oncology
CHRS
+$86.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 41.74%
2 Industrials 21.19%
3 Healthcare 12.8%
4 Financials 7.52%
5 Materials 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
26
Regeneron Pharmaceuticals
REGN
$70.9B
$85.2M 0.5%
190,621
+13,068
+7% +$6.22M
WP
27
DELISTED
Worldpay, Inc.
WP
$69.2M 0.4%
+982,057
New +$66.9M
TOUR
28
Tuniu
TOUR
$55.2M
$64.1M 0.37%
819,444
VNET
29
VNET Group
VNET
$2.1B
$61.3M 0.36%
10,778,004
ILMN icon
30
Illumina
ILMN
$28.2B
$55.2M 0.32%
285,024
MON
31
DELISTED
Monsanto Co
MON
$51.4M 0.3%
429,184
+213,650
+99% +$25.1M
KREF
32
KKR Real Estate Finance Trust
KREF
$469M
$51.3M 0.3%
2,439,024
ATH
33
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$46.4M 0.27%
862,204
JUNO
34
DELISTED
Juno Therapeutics, Inc.
JUNO
$41.1M 0.24%
915,750
EMWP
35
DELISTED
Eros Media World PLC
EMWP
$39.4M 0.23%
137,766
ONC
36
BeOne Medicines Ltd
ONC
$32.4B
$39.3M 0.23%
380,000
CELG
37
DELISTED
Celgene Corp
CELG
$37.2M 0.22%
255,406
+49,219
+24% +$6.7M
VRTX icon
38
Vertex Pharmaceuticals
VRTX
$123B
$37.2M 0.22%
244,582
+50,383
+26% +$7.58M
BIIB icon
39
Biogen
BIIB
$30.4B
$37.1M 0.22%
118,644
+23,418
+25% +$6.93M
AMGN icon
40
Amgen
AMGN
$198B
$35.2M 0.2%
188,527
+37,217
+25% +$6.59M
INCY icon
41
Incyte
INCY
$23.4B
$29.4M 0.17%
252,160
+50,856
+25% +$6.43M
KRE icon
42
State Street SPDR S&P Regional Banking ETF
KRE
$4.97B
$29.3M 0.17%
515,700
NETS
43
DELISTED
Netshoes (Cayman) Limited
NETS
$27.2M 0.16%
2,071,127
JPM icon
44
JPMorgan Chase
JPM
$907B
$25.2M 0.15%
264,337
IBN icon
45
ICICI Bank
IBN
$107B
$24M 0.14%
2,808,987
BAC icon
46
Bank of America
BAC
$430B
$20.2M 0.12%
798,123
NTLA icon
47
Intellia Therapeutics
NTLA
$1.59B
$19.6M 0.11%
790,527
ACIU icon
48
AC Immune
ACIU
$224M
$14.9M 0.09%
1,337,500
WFC icon
49
Wells Fargo
WFC
$265B
$14.4M 0.08%
260,364
AMRS
50
DELISTED
Amyris Inc.
AMRS
$10.6M 0.06%
3,302,585

Similar funds

Temasek Holdings's Q3 2017 Portfolio in Review

As of Q3 2017, Temasek Holdings held 63 positions worth $17.2B, up 11% from $15.5B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Temasek Holdings deployed $584M of net new capital in Q3 2017, opening 4 new positions and adding to 16 existing holdings. Its largest new stake was Coherus Oncology: 6,556,116 shares worth $87.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 42% of assets, up from 38% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was IHS Markit Ltd. Common Shares, an estimated $177M trimmed.

  • Temasek Holdings's largest Q3 2017 buy was Coherus Oncology: 6,556,116 shares worth $87.5M.
  • Temasek Holdings added most to Visa in Q3 2017, an estimated $180M increase.
  • Temasek Holdings's biggest Q3 2017 reduction was IHS Markit Ltd. Common Shares, cutting an estimated $177M.
  • Temasek Holdings fully exited Link Motion Inc. in Q3 2017, selling an estimated $828K.
  • Temasek Holdings's ten largest holdings make up 78% of its $17.2B portfolio in Q3 2017.
  • Temasek Holdings opened 4 new positions and closed 2 in Q3 2017.
  • Temasek Holdings's portfolio value rose 11% quarter-over-quarter to $17.2B.

Based on Temasek Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.